Rats i.p. injected once with 10 mg/kg kainic acid exhibited clear seizure behavior ("wet-dog shakes," rearing on the hindlimbs, and bilateral clonus). Pretreatment with L-arginine (L-Arg twice a day for 5 days) significantly decreased these manifestations. The medium dose of L-Arg (40 mg/kg) was found to be close to optimum; 10 and 160 mg/kg L-Arg provided much smaller positive effects. In KA-treated rats, a much higher density of GFAP-positive astrocytes was found in the hilus of the dorsal hippocampus, while 40 mg/kg L-Arg+KA-treated rats demonstrated noticeably weaker GFAP overexpression. The results of Western blotting analysis were fully comparable with those obtained in the immunostaining experiments.
INTRODUCTION
L-Arginine (L-Arg) first isolated in 1886 is one of the 20 most common natural amino acids. In mammals, arginine is classified as a semiessential or conditionally essential amino acid (depending on the developmental stage and health status of the individual) [1] . Preterm infants are unable to synthesize arginine internally, making this amino acid nutritionally essential for them [2] . There are some conditions that cause increased requires of the organism for the synthesis of L-arginine, including surgical or other trauma, sepsis, and burns. It should be taken into consideration that L-Arg is the substrate for nitric oxide (NO) synthesis.
Kainic acid (KA) is a natural organic acid existing in some seaweed. It is a specific agonist for the kainate receptors, a subtype of ionotropic glutamate receptors for which KA can imitate the effect of glutamate. Kainic acid is a potent stimulant of the CNS used for the induction of seizures in experimental animals; in particular, KA allows experimenters to build up a rat model of epilepsy. As was demonstrated earlier, NO may alleviate seizures and, thus, may be a kind of endogenous antiepileptics [3] . However, the mechanism of NO action in this respect still remains unclear.
It has been reported that reactive proliferation of astrocytes occurs during the process of neurodegeneration or brain injury, and this is accompanied by intensification of the synthesis of glial fibrillary acidic protein (GFAP), a cell-specific marker for reactive astrocytes [4] [5] [6] . Increased GFAP immunoreactivity [7] [8] and the respective mRNA levels were found in seizure-manifesting rats [9] [10] [11] . The question whether L-Arg, an important component of the NO system, exerts any effect on the expression of GFAP has not yet been clarified. This is why we investigated the effects of L-Arg on seizure behavior and expression of GFAP in KA-treated rats. movements of the head and trunk called "wet dog shakes" (WDSs). The onset of seizures and the degree of their severity were estimated using a point scale proposed by Racine [12] : 1, chewing; 2, head nodding; 3, unilateral forelimb clonus; 4, rearing with bilateral forelimb clonus; and 5, rearing with bilateral forelimb clonus and falling back. Behavior of KA-treated rats was monitored for 3 h after KA administration.
Immunohistostaining. After observing seizure behavior, the rats were i.p. anesthetized with pentobarbitone and perfused transcardially with 4% paraformaldehyde. The brains were removed and immersed in 20% sucrose diluted in 0.1 M phosphatebuffered saline (PBS, pH 7.4). Brain samples were cut into 50-mm-thick slices. The latter were first rinsed in PBS for 10 min and then consequently incubated with bovine serum albumin (BSA) for 30 min, incubated with the primary GFAP antibody (1:3,000) overnight at 4°C, rinsed in PBS for 10 min, and then incubated with biotinylated goat anti-rabbit serum (1:500) and avidin-biotin complex (ABC) for 3 h. Diaminobenzidine (DAB) provided visualization of staining. Control sections were incubated with PBS instead of the primary antibody.
Pathological Image Analysis. A HPIAS series colorful pathology photograph system was used to analyze GFAP-immunopositive (ip) cells. The testsquares in the screen of the microscope used were 194,258 mm 2 , and the number and average optical density of GFAP-ip cells were measured within these squares.
Western Blotting Analysis. Hippocampal samples were removed, weighed, homogenized in Tris buffer saline (TBS, pH 7.5) for 15 sec, and then vigorously vortexed for 10 sec. Parts of the homogenized samples (100 ml) were heated at 100°C for 5 min and then centrifuged at 13,000 rpm for 5 min. Ten microliters of the supernatant were used for quantifying protein according to the Smith's method [11] . Another 100 ml of homogenized samples were added to an equal volume of the sample loading buffer, heated at 100°C for 5 min, and then centrifuged at 13,000 rpm for 5 min. After these procedures, electrophoresis, transferring, and identifying were carried out. Markers were cut away from the membrane, stained, destained, and dried, while the other part of the membrane was washed twice with TBS for 10 min and then immobilized by 1% BSA for 1 h. Next operations were incubation with the primary antibody against GFAP (1:1,500) and subsequent incubation with the secondary antibody and ABC for 1 h. Finally, photographs were taken and analyzed.
Statistics. The numerical results are shown as means ± s.d., and the one-way ANOVA test was used to evaluate the statistical significance (P < 0.05).
RESULTS
Behavior. The KA-treated rats in the model group exhibited clear time-dependent seizure behavior. Five minutes after KA injection, staring and WDSs occurred during 30 min to 1 h. Spontaneous stereotyped seizure behavior happened within a 1-to 3-h-long interval; this was characterized by rearing on the hindlimbs with bilateral clonus, until the balance was lost. In comparison with the control group, animals of the 160 mg L-Arg + 10 mg/kg KA-injected group showed much longer WDS latencies with insignificant differences in the rearing latency and seizure scores. However, 40 mg/kg L-Arg + KA-treated rats showed much longer WDS latencies and rearing latencies with lower seizure scores, while 10 mg/kg L-Arg + KA-treated group showed no significant changes. These results suggested that 10 mg/kg L-Arg practically did not alleviate the normal condition, while 40 mg/kg L-Arg alleviated the condition obviously. This proved that the effect of L-Arg on abnormal behavior induced by KA is dose-dependent, and that the optimum dose of L-Arg is about 40 mg/kg, as illustrated in Table 1 .
Immunohistostaining Analysis. In comparison with the control group, the number and the density Footnotes. **Significant difference from physiological saline (PS) + KA-injected group with P < 0.01 (n = 10). WDS) "Wet dog shakes" (brist rotational movements of the head and trunk).
of GFAP-ip astrocytes in KA-treated rats were significantly greater in the hilus of the dorsal hippocampus. A bandlike distribution of astrocytes was clearly observed, the general intensity of staining of the GFAP-ip units was markedly greater, and strongly labeled immunoreactive elements were almost entirely located in the hilus and adjacent regions. A majority of the GFAP-ip cells appeared larger and were stained more heavily, with positive processes appearing more clearly. However, 40 mg/kg L-Arg + KA-treated rats demonstrated noticeably weaker overexpression of GFAP-ip astrocytes mentioned above; there was no statistically significant difference from the expression in the control groups ( Fig. 1 and Table 2 ). Western Blotting Analysis. The molecular mass of GFAP is about 50 kDa. Three hours after KA injection, GFAP expression was obviously more intense in the PS-treated + KA-injected group. At the same time, such expression in the 40 mg/kg L-Arg + KA-rats was noticeably weaker and showed no significant difference vs that in the PS-injected group (Figs. 2 and 3) . These results are fully comparable with those obtained in the immunohistostaining experiments. . * Significant difference from the control PS-injected group at P < 0.05. ** Significant difference from the control PS-injected group at P < 0.01. ## Significant difference from the PS + KA-injected group at P < 0.01. Other designations are the same as in Table 1 . 
DISCUSSION
Nitric oxide has been implicated in mediation of neuronal excitotoxic injury [14] [15] . L-arginine (the substrate for NO synthesis), regarded as the main endogenous source for NO production, was used in our experiments to study the role of NO in generation of seizures in KA-treated rats. It was reported earlier that pretreatment with L-Arg tends to potentiate the effects of quinolinic acid (QA) and induces clonic and tonic convulsions in mice [16] . Simultaneously, the effects of L-Arg on seizure activity elicited by KA are dose-dependent and contribute to the genesis of seizure activity [17] . At the same time, it was found that L-Arg did not affect kindling or seizure severity [18] . Other studies showed that NO might act as an endogenous anticonvulsant in mice [19] [20] , and the anticonvulsant L-Arg alone significantly increases the NO concentration and NOS activity in specific brain regions responsible for suppression of convulsions [21] [22] . Previous studies, however, indicated that KA-induced seizures appeared later in rats pretreated with a single large dose of L-Arg [18] [19] [20] [21] .
Due to all the above-mentioned controversies, we investigated the effects of chronic treatment with small doses of L-Arg on KA-induced seizures. The results showed that pretreatment with 40 mg/kg L-Arg clearly alleviated KA-induced seizures, while pretreatment with the lower (10 mg/kg) or greater (160 mg/kg) doses of L-Arg demonstrated less significant effects. Thus, the dose dependence is probably U-like.
The results presented here indicate that chronic treatment with moderate doses of L-Arg (40 mg/kg) provides an obvious anticonvulsant action, but the mechanism of such effect still remains unclear. As is known, astrocytes perform a variety of functions in the adult CNS [23] [24] . Reactive gliosis is a response of astrocytes to a variety of insults that is characterized by hypertrophy of the cell bodies and processes and an increase in the expression of GFAP [25] [26] . Previous studies revealed that a single KA-induced seizure episode strongly intensifies GFAP expression in astrocytes in the hippocampal formation. Bennett et al. reported that GFAP immunopositivity was enhanced in the hippocampus and correlative brain areas 3 h after KA injection, but the specific distribution and alteration were not described [27, 28] . Our results showed that weaker GFAP expression after L-Arg pretreatment correlates with reduced KA-challenged seizure behavior. Furhtermore, L-Arg pretreatment with the dosage of 40 mg/kg inhibited hyperplasia and hypertrophy of the astrocytes and bandlike distribution of these glial cells and also alleviated the abnormal overexpression of GFAP induced by KA.
Thus, our study suggests that the effect of NO on KA-induced seizures is dose-dependent, and that the L-Arg dose of 40 mg/kg seems to be optimum for correction of KA-induced abnormal behavior. The effect may be related to regulation of the expression of GFAP and to a protecting action with respect to astrocytes. In future, we will try to block NO expression and to observe behavioral changes and changes in astrocytes in KA-treated animals. It 
